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Genetic and pharmacological studies demonstrate that Endothelin1 (Edn1) is a key signaling molecule for patterning the facial skeleton in fish,
chicks, and mice. When Edn1 function is reduced early in development the ventral lower jaw and supporting structures are reduced in size and
often fused to their dorsal upper jaw counterparts. We show that schmerle (she) encodes a zebrafish ortholog of Phospholipase C, beta 3 (Plcβ3)
required in cranial neural crest cells for Edn1 regulation of pharyngeal arch patterning. Sequencing and co-segregation demonstrates that two
independent she (plcβ3) alleles have missense mutations in conserved residues within the catalytic domains of Plcβ3. Homozygous plcβ3 mutants
are phenotypically similar to edn1 mutants and exhibit a strong arch expression defect in Edn1-dependent Distalless (Dlx) genes as well as
expression defects in several Edn1-dependent intermediate and ventral arch domain transcription factors. plcβ3 also genetically interacts with
edn1, supporting a model in which Edn1 signals through a G protein-coupled receptor to activate Plcβ3. Mild skeletal defects occur in plcβ3
heterozygotes, showing the plcβ3 mutations are partially dominant. Through a morpholino-mediated deletion in the N-terminal PH domain of
Plcβ3, we observe a partial rescue of facial skeletal defects in homozygous plcβ3 mutants, supporting a hypothesis that an intact PH domain is
necessary for the partial dominance we observe. In addition, through mosaic analyses, we show that wild-type neural crest cells can efficiently
rescue facial skeletal defects in homozygous plcβ3 mutants, demonstrating that Plcβ3 function is required in neural crest cells and not other cell
types to pattern the facial skeleton.
© 2006 Elsevier Inc. All rights reserved.Keywords: Dlx; Endothelin1; Neural crest; plcβ3; schmerleIntroduction
Genetic analyses in mice support the hypothesis that during
embryonic development the ligand Endothelin1 (Edn1) signals
through a receptor [Endothelin receptor type A (Ednra)] that is
coupled to G proteins of the Gq/G11 family (Clouthier et al.,
2000; Dettlaff-Swiercz et al., 2005; Ivey et al., 2003; Kurihara
et al., 1994). Mice carrying mutations in Edn1, Ednra, and
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doi:10.1016/j.ydbio.2006.12.027lower jaw cartilages are severely reduced in size and are fused to
their dorsal upper jaw counterparts. Zebrafish with mutations in
furinA (an activator of the Edn1 ligand) and edn1 (Piotrowski et
al., 1996) also have facial skeletal defects resembling those of
the mouse Edn1 pathway mutants, demonstrating that the Edn1
signaling pathway functions broadly within jawed vertebrates to
give ventral character to the facial skeleton (Miller et al., 2000;
Walker et al., 2006). In this paper, we expand the number of
Edn1 pathway mutants so far known in either mouse or
zebrafish by showing that the craniofacial gene schmerle
encodes a zebrafish ortholog of Plcβ3 that plcβ3 mutants have
facial skeletal defects similar to edn1 mutants, and that plcβ3
and edn1 genetically interact. We will refer to schmerle (she) as
plcβ3 for the remainder of the paper.
Phospholipase C enzymes are effectors of signal transduc-
tion pathways coupling an agonist-stimulated cell surface
receptor to the intracellular production of the secondary
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2001). These messengers then promote the activation of protein
kinase C and the release of Ca2+from intracellular stores,
inducing a wide variety of cellular functions. Plcβ3 is member
of the beta class of Phospholipase C enzymes containing four
family members, Plcβ1-4 (Rebecchi and Pentyala, 2000; Rhee,
2001). Plcβs are modular proteins containing an N-terminal PH
(pleckstrin homology) domain, EF-hand domains, catalytic X
and Y domains, a C2 domain, and a C-terminal myosin tail. The
PH domain binds membrane phosphoinositides and promotes
targeting of Plcβ enzymes to the plasma membrane. The
catalytic X and Y domains are both required for the hydrolysis
of PIP2 to IP3 and DAG. The myosin tail domain is unique to
Plcβ type enzymes. All four Plcβ family members are can be
activated by G proteins of Gq/G11 family, and all but Plcβ4 are
also activated by Gβγ (Lee et al., 1994; Smrcka and Sternweis,
1993).
Mice bearing mutations in Plcβ1, Plcβ2, and Plcβ4 family
members are homozygous viable but exhibit specific defects
(Chakrabarti et al., 2003; Li et al., 2000). Plcβ1 mutants die due
to epileptic-like seizures, Plcβ2 mutants have enhanced
responses to chemoattractants, and Plcβ4 mutants have defects
in motor coordination and vision (Hashimoto et al., 2001). Two
independent Plcβ3 mouse mutants have markedly different
phenotypes (Wang et al., 1998; Xie et al., 1999). Xie et al.
(1999) report that Plcβ3 deficient mice are homozygous viable
with skin tumors and enhanced sensitivity to morphine, while
Wang et al. (1998) report that Plcβ3 deficient mutants are early
embryonic lethal. These discrepancies in Plcβ3 mutant mouse
phenotypes may be due to differences in the deletion constructs
used.
We report that independent zebrafish mutations in conserved
X and Y catalytic domain residues of Plcβ3 yield facial skeletal
phenotypes similar to edn1 pathway mutants (Miller et al.,
2000). Heterozygous plcβ3 mutants have mild facial skeletal
phenotypes resembling a partial loss of Edn1 function, while
homozygous plcβ3 mutants have severe facial skeletal pheno-
types resembling a strong loss of Edn1 function (Miller and
Kimmel, 2001). We provide evidence that the plcβ3 catalytic
domain mutations act in a dominant-negative manner, affecting
the function not only of Plcβ3 but of other Plcβ family
members as well. We further show through mosaic analyses that
Plcβ3 function is autonomously required in neural crest cells
specifically to pattern the facial skeleton.Materials and methods
Fish stocks and maintenance
Fish were raised under standard conditions and occasionally with the
addition of 0.0015% PTU (1-phenyl 2-thiourea) to inhibit melanogenesis
(Westerfield, 1993). Stages are given in hours postfertilization (hpf) at 28.5 °C
(Kimmel et al., 1995). plcβ3tg203e and plcβ3th210 alleles, which are homozygous
lethal, were generously provided by Drs. Tatjana Piotrowski and Christiane
Nusslein-Volhard. The suckertf216b (endothelin1) mutants have been previously
described (Miller et al., 2000). We obtained homozygous mutant embryos from
natural matings of heterozygous carriers maintained on an inbred AB genetic
background. plcβ3th210 was used for all phenotypic analyses unless notedotherwise. fli1-GFP albino transgenic fish, TG(fli1:EGFP)y1;albb4, have been
previously described (Lawson and Weinstein, 2002).
Tissue labeling procedures
Alcian green was used to stain the cartilage of 4–6 days postfertilization
(dpf) fixed larvae. Facial cartilages were dissected out and prepared as flat
mounts (Kimmel et al., 1998). Double Alcian blue (cartilage) and Alizarin red
(bone) staining were done on 4–6 dpf fixed larvae using a modified “acid-free”
protocol (Walker and Kimmel, in press). Whole-mount RNA in situ
hybridizations were performed using digoxigenin-labeled riboprobes (Miller
et al., 2000). plcβ3 probe was made with a 2-kb c-terminal cDNA clone.
References for other probes are: dlx5a, dlx6a, barx1 (Walker et al., 2006),
dlx2a, dlx3b, gsc, and hand2 (Miller et al., 2000), bapx1 (Miller et al., 2003),
runx2b (Flores et al., 2004), islet1 (Appel et al., 1995), and sox9a (Yan et al.,
2002).
Mapping, sequence, and co-segregation analysis of plcβ3 Alleles
We first mapped the schmerle allele, shetg203e to chromosome 7 on a hybrid
TF/AB genetic background using bulked segregant analysis (Knapik et al., 1996).
Individual diploid embryos were sorted into mutant and wild-type classes based
on an open-mouth phenotype. The heads of these embryos were stained with
Alcian green to confirm segregation of the mouth phenotypes with jaw skeletal
defects, and DNA was prepared from the tails and amplified using primers
flanking simple sequence-length polymorphisms. Finer mapping placed shetg203e
between the microsatellite markers Z7958 and Z8540 using a mapping panel
containing 67 mutant and 29 wild-type diploid embryos. cDNAs were prepared
from pools of mutant and wild-type sibling embryos by RT-PCR. Briefly, total
RNAwas isolated with Trizol (BRL) and primed for first strand cDNA synthesis
using Superscript II reverse transcriptase (BRL) and oligo dT primer. Using
sequence from the genomic clones Al772136 and BX511067, we designed
primers to obtain overlapping cDNAs covering the full-length coding region of
plcβ3 as follows: RT-PCR using external primers 5′CCGTTGTTACACT-
GAAGGT3′/5′GTTTAGTGCCACCATCTG3′ followed by nested primers 5′
GAAACTTCCAACCGAGAAG3′/5′CACGTTCCAGAAAAGCTGTG3′
yielded an n-terminal 2.0 kb plcβ3 cDNA. RT-PCR using external primers 5′
GCAAATGAGTCGCATTTACC3′/5′CGTACAACTTCTAGTAATAC3′ fol-
lowed by nested primers 5′CAAAGGGACTCGTGTGGAC3′/5′GAGAATA-
GAAATCGATTTGAAG3′ yielded a c-terminal 2.0 kb cDNA. These PCR
products were sequenced directly using an ABI automated sequencer.
Morpholino antisense oligonucleotide injections
Translation-blocking and splice site-blocking morpholinos (MOs) were
purchased from Gene Tools, Inc. plcβ3 splice site MO: 5′TTGTCGTGGTTA-
CCTTGCAATAGCC3′ plcβ3 translation MO: 5′CATGGCTGCTGAATC-
GACGGGTGG3′ (sequence complementary to the start codon is underlined).
Roughly 2 nl of MOs diluted to 0.5–10 mg/ml in 0.2 M KCl and 0.2% phenol
red was pressure-injected into the yolk of 1–4 cell zebrafish embryos. For Table
1, the following MO amounts were used: WT+splice MO, 10 ng; WT+
translation MO, 6 ng; WT+splice/translation MO, 10 ng and 3 ng, respectively;
plcβ3−/−+splice MO, 6 ng.
Tissue transplantation and confocal imaging
Tissue transplants were as described (Crump et al., 2004a,b). An ‘Alexa568’
mixture of 2% Alexa Fluor 568 dextran and 3% lysine-fixable biotin dextran
(10,000 MW, Molecular Probes) was injected into the yolk of donor embryos at
1–4 cell stage. For neural crest transplants, donor tissue was taken from the
animal cap at shield stage (6 hpf) and moved to shield stage host embryos to a
position approximately 90° from the shield and 70° from the animal pole. For
ectoderm transplants animal cap donor transplants were moved to shield stage
host embryos to a position approximately 120° from the shield and 40° from the
animal pole. For endoderm transplants donor embryos were additionally injected
with TAR*RNA and margin donor tissue moved to 40% epiboly hosts (4 hpf) to
margin position. All transplants were unilateral. Host embryos were screened at
Table 1
Penetrance of skeletal phenotypes in plcβ3 mutants
Class Number scored Joint loss Severe ventral cartilage loss
A1 A2 A1 A2 A3 A4 A5 A6 A7
A. Cartilage phenotypes
−/− 164 100% 100% 62% 89% 80% 26% 0% 0% 0%
+/− 148 26% 0% 0% 0% 0% 0% 0% 0% 0%
+/+ 70 0% 0% 0% 0% 0% 0% 0% 0% 0%
Class Number scored Number ectopic cartilage nodules/embryo
0 1 2 3 3+
−/− 164 1% 3% 8% 19% 68%
+/− 148 28% 49% 17% 5% 1%
+/+ 70 0% 0% 0% 0% 0%
Class Number scored Bone loss Bone gain Bone fusion
OP BR OP BR OP/BR
B. Bone phenotypes
−/− 164 70% 99% 18% 0% 1%
+/− 148 0% 0% 8% 0% 3%
+/+ 70 0% 0% 0% 0% 0%
At 6 dpf, larvae were fixed and stained for both cartilage and bone.
‘Number scored’ refers to embryos scored. Severe ventral cartilage loss is
defined as cartilages that are less than half the size of its wild-type counterpart.
For the class ‘+/−’, only larvae with phenotypes are included in the table.
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animals with greater than a quarter donor tissue contributing to neural crest,
endoderm, or ectoderm were selected for analysis. Animals were imaged using a
Zeiss LSM5 Pascal confocal fluorescence microscope and subsequently fixed
and doubly stained for cartilage (Alcian blue) and bone (Alizarin red) at 6 dpf.
GenBank accession numbers
plcβ3 EF204528.Results
plcβ3 mutants have defects in the intermediate and ventral
domain elements of the pharyngeal skeleton
Two schmerle (phospholipase C, beta 3) alleles, which we
shorten to plcβ3 (see evidence presented below), were isolated
in a large-scale mutagenesis screen and placed into a class with
mutants at three other loci [sucker (edn1), sturgeon (furinA),
and hoover], which disrupt dorsoventral patterning of the
anterior pharyngeal arches (Miller et al., 2000; Piotrowski et al.,
1996). In plcβ3 homozygotes, the dorsal and ventral cartilages
of the anterior arches are fused at an intermediate position
corresponding to joint regions, and ventral cartilages are
reduced in length in arches 1–4, but not in arches 5–7 (Figs.
1E, H; Table 1). In particular, the ventral cartilage (ceratohyal)
of the second arch is severely reduced in homozygotes, with
nubbins of cartilages persisting near the ventral midline (Fig.
1H, arrowheads). Ectopic cartilage nodules are frequently
positioned ventrally, such as near the basihyal (Fig 1H,
asterisks; Table 1). For the dorsal opercle bone in the second
arch, we observe both loss and gain (expansion) phenotypes(Kimmel et al., 2003b), while the corresponding ventral bone,
the branchiostegal ray posterior, is frequently missing (Table 1).
We also discovered that the plcβ3 mutant phenotype is partially
dominant, a characteristic not previously reported (Kimmel et
al., 1998; Kimmel et al., 2003a). In plcβ3 heterozygotes, there is
a variable penetrance of mild facial skeletal defects, similar in
nature but much less severe than those of homozygous plcβ3
mutants (Figs. 1F, I; Tables 1 and 3). These mild facial skeletal
defects include joint fusions, reductions in the length of the
symplectic region of the hyomandibular cartilage, ventrally
localized ectopic cartilage nodules, and mild changes in the
shape of the opercle and branchiostegal ray bones. Both plcβ3
alleles yield skeletal phenotypes with similar penetrance and
expressivity.
The skeletal defects, we observe in plcβ3 mutants are
reminiscent of those in edn1 and furinA mutants, suggesting all
three genes may function within a common genetic pathway
(Kimmel et al., 1998; Miller et al., 2000; Piotrowski et al., 1996;
Walker et al., 2006). In all three mutants, skeletal defects are
isolated to the anterior four arches, with cartilages of the
posterior three arches having near wild-type appearance. furinA
homozygotes are milder in phenotype than plcβ3 homozygotes
as furinA homozygotes typically do not have strong reductions
of ventral facial cartilages. Similarly, plcβ3 homozygotes are
slightly less severe in phenotype than edn1 homozygotes as
reductions of ventral cartilages are more penetrant in edn1
homozygotes than in plcβ3 homozygotes.
plcβ3 alleles have lesions in the catalytic domain of Plcβ3
We mapped plcβ3tg203e to zebrafish chromosome 7 using
bulk segregant analysis (Knapik et al., 1996). Finer mapping
placed plcβ3tg203e at 60.7 cM, flanked by the microsatellite
markers, Z7958 and Z8540 (Fig. 2A). A zebrafish EST to cct7
also mapped to this interval between Z7958 and Z8540. We
confirmed tight linkage of cct7 to she using the primers 5′
CAAAGCACAACTTACTTCTACAC3′/5′CCATTCAATC-
TAAGACTTCTAAG3′ flanking a CA repeat adjacent to cct7.
As an insertional zebrafish mutation in cct7 does not have
phenotypes similar to those of she mutants, we did not consider
cct7 a likely candidate for she, but rather used this positional
linkage to look for potential candidates. cct7 is located on
Zv4_scaffold645.2 at 51.4 MB on LG7. Nearby at 51.9 Mb, on
AL772136 is sequence highly similar to human Plcβ3. We
considered plcβ3 an excellent candidate as the ligand Edn1
signals through a receptor (EdnrA), which is coupled to G-
proteins of the Gq/G11 family (Ivey et al., 2003). This family of
G proteins regulates the function of Plcβ family members,
including that of Plcβ3.
For plcβ3tg203e a T-to-Cmutation results in the transformation
of a conserved lysine to proline in the Y domain of the catalytic
domain (Figs. 2B, C); segregation with the mutant phenotype
was confirmed by PCR genotyping 67 mutant diploid embryos
(data not shown). As this transformation results in the loss of a
PvuII restriction enzyme site in mutant embryos, primers 5′
GTGAGACATGAACATAGCTG3′/5′GACTTTAACTG-
TATTGGCTAC3′ were used followed by PvuII digestion. For
Fig. 1. plcβ3mutants have defects in facial skeletal patterning. (A–C) Lateral views of live wild-type, plcβ3 homozygous, and plcβ3 heterozygous larvae at 6 dpf. plcβ3
homozygotes have an open-mouth phenotype and fail to form a swimbladder (white asterisk in panel A). (D–F) Flat mounts of wild-type, plcβ3 homozygous, and plcβ3
heterozygous larvae Alcian-green-stained mandibular and hyoid cartilages at 6 dpf. Homozygotes have fusions at the joint region between the palatoquadrate and
Meckel's cartilage of the mandibular arch and strong reductions in the symplectic and ceratohyal cartilages of the hyoid arch. Meckel's cartilage is less severely reduced
in length and the palatoquadrate is reduced and/or misshaped. Wild-type D/V joint regions are indicated with arrows in panel D. Fusions at joint regions in plcβ3
homozygotes are indicated with asterisk in panel E. Reductions in symplectic cartilage in plcβ3 heterozygotes are indicated with asterisk in panel F. Cartilages are
labeled as followed: pq (palatoquadrate), mc (Meckel's cartilage), hm (hyomandibula), ch (ceratohyal), sy (symplectic), and ih (interhyal). Two bones of hyoid arch are
also lightly stained with Alcian green: op (opercle), bsrp (branchiostegal ray posterior). The opercle is frequently reduced or expanded in plcβ3 heterozygotes, while
branchiostegal ray posterior is frequently absent. (G–I) Flatmounts of wild-type, plcβ3 homozygous, and plcβ3 heterozygous larvae doubly stainedwith Alcian blue and
Alizarin red for cartilage and bone, respectively. In homozygotes ectopic cartilage nodules are frequently located near basihyal (bh) cartilage (asterisks in panel H).
Ceratohyal cartilages are also +-frequently reduced to nubbins (arrowheads in panel H). Anterior ceratobranchials (cb) are typically reduced in length. Ceratobranchials
are indicated with dots in panel G. In heterozygotes ectopic cartilage nodules frequently extend from the palatoquadrate cartilage (asterisk in panel I). Scale bars: 50 μm.
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conserved serine to phenylalanine in the X domain of the
catalytic domain (Figs. 2B, C); segregation with the mutant
phenotype was confirmed by PCR genotyping 74 mutant diploid
embryos (data not shown). Primers 5′CACCTTACCCTCT-
GAACCTGT3′/5′CCAAGGTAAGATATACACAATG 3′ were
used to turn the th210 lesion into a co-dominant polymorphism
following XmnI restriction enzyme digestion.
A splice-blocking morpholino-mediated deletion in the PH
domain of plcβ3 partially rescues plcβ3 homozygotes
To demonstrate that a loss of plcβ3 function can cause the
mutant phenotypes we observe, we designed both translation-
and splice-blocking plcβ3 MOs. We designed a plcβ3 splice-
blocking MO to exon 4 donor splice site. Exon 4 encodes part of
the N-terminal PH domain, a domain critical for both substrate
binding and membrane localization. We tested the effectiveness
of the plcβ3 splice-blocking MO in blocking splicing by
analyzing the structure of plcβ3 mRNA in uninjected wild-
type and plcβ3 splice-blocking MO injected embryos at 1 dpf byRT-PCR. In plcβ3 splice-blocking MO injected embryos, we
detect a smaller splice variant of plcβ3 and failed to detect wild-
type plcβ3 splice product by RT-PCR (Fig. 2D). Sequencing
confirms this splice variant results in the deletion of 17 amino
acids within the PH domain of Plcβ3 (Fig. 2E). Our splice MO
would therefore be predicted to be effective at interrupting Plcβ3
gene function by affecting substrate binding and membrane
localization.
Injections of the plcβ3 splice-blocking MO into wild-type
embryos resulted in embryos with a low penetrance of mild
facial skeletal defects (phenotypic index 2) (Table 2; Fig. 3B).
The mild phenotypes are surprising as our evidence above
suggests the splice-blocking MO is effective at blocking
Plcβ3 function. These skeletal defects are similar to those we
observe in plcβ3 heterozygotes and are less severe than plcβ3
homozygotes (phenotypic index 4). Injections of a translation-
blocking MO yielded similar results (Table 2). Co-injections
of translation- and splice-blocking MOs into wild-type
embryos significantly increased the penetrance of observed
phenotypes, but only slightly increased the severity of skeletal
defects (Table 2).
Table 2
Phenotypic Severity Index of plcβ3 mutants and morpholino injected larvae
Class Number
scored
Phenotypic index
1
(wt)
2
(mild)
3
(moderate)
4
(severe)
WT 92 100% 0% 0% 0%
WT+splice MO 86 71% 29% 0% 0%
WT+translation MO 78 78% 22% 0% 0%
WT+splice/translation MO 48 10% 79% 10% 0%
plcβ3−/− 179 0% 1% 2% 97%
plcβ3+/− 148 * 97% 3% 0%
plcβ3−/−+splice MO 20 0% 50% 50% 0%
Morpholinos were injected into the yolk of 1–4 cell stage embryos. At 4–6 dpf,
larvae were fixed and stained for both cartilage and bone. Scoring was done
blindly, prior to determining genotype. ‘Number scored’ refers to larvae scored.
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be highly effective at disrupting Plcβ3 function, it is
important to understand why the plcβ3 MO phenotypes are
much less severe than the plcβ3 homozygous phenotypes.
The work of Nagano (see Discussion) provides an explana-
tion, namely that the plcβ3 mutations affecting the catalytic
domain generates mutant proteins that act as dominant
negatives, blocking the function of Plc family members that
are also contributors to patterning in wild type. A prediction
of this hypothesis is that if the dominance of the plcβ3 alleles
is mediated through substrate binding and/or membrane
localization, our splice-blocking MO would relieve this
inhibition since it deletes part of the PH domain. We verified
this prediction: Injection of the splice-blocking MO intoPhenotypic classes are defined as follows: 1 (wt)=phenotypically similar to
uninjected wild-type embryos. 2 (mild)=Similar to Figs. 1F and I and may have
shortened symplectic cartilage, ectopic cartilage, bone fusion, or unilateral joint
loss without severe cartilage reduction. 3 (moderate)=More severe than Figs. 1F
and I but less severe than Fig. 1H. May have bilateral joint losses and mild
reduction in ventral cartilage. 4 (severe)=Similar to Fig. 1H, with bilateral joint
losses and severe ventral cartilage reductions.
*For the class ‘plcβ3+/−’, only larvae with phenotypes are included in the table.plcβ3 homozygotes (genotyped by PCR) resulted in a strong
decrease in severity of facial skeletal phenotypes, including
rescue of joint loss and ventral cartilage reductions (Figs. 3C,
D; Table 2). Whereas over 90% of uninjected plcβ3
homozygotes have severe phenotypes (phenotypic index 4),
none of the splice-blocking MO injected plcβ3 homozygotes
had severe phenotypes. This partial rescue strongly supports
the hypothesis that the plcβ3 mutations act in a dominant-
negative manner.
plcβ3 is expressed in the pharyngeal arches and in neuronal
cells
The homozygous plcβ3 mutant phenotype is similar to that
of Edn1 pathway mutants, suggesting Plcβ3 functions in the
Edn1 pathway (Miller et al., 2000; Walker et al., 2006). SinceFig. 2. Segregation and sequence analysis of two plcβ3 alleles and plcβ3 MO
splice variant. (A) schmerle (plcβ3) maps to Danio rerio chromosome 7
between microsatellites Z7958 and Z8540. (B) Schematic of protein domains in
plcβ3+(wt) and lesions in plcβ3tg203e and plcβ3th210. Sequence around lesion
sites is aligned with other vertebrate Plcβ3 and with Plc in fly. Dots indicate
sequence identity. Abbreviations: PH (pleckstrin homology), EF (EF hand), C2
(protein kinase C conserved region 2). (C) Sequence chromatograms of plcβ3-
and plcβ3th210 around lesion sites in plcβ3. In plcβ3tg203e a T-to-C mutation
results in the transformation of a conserved serine to a phenylalanine in the X
domain of the catalytic domain. In plcβ3th210 a C-to-T mutation results in the
transformation of a conserved leucine to proline in the Y domain of the catalytic
domain. (D) RT-PCR analysis of plcβ3 mRNA structure in wild-type and splice
MO-injected embryos. plcβ3 splice-blocking MO is complementary to exon 4
splice donor site. Primers designed to exon1 and exon5 were used in RT-PCR of
uninjected and plcβ3 splice-blocking MO injected embryos at 1 dpf (5′
CCGTTGTTACACTGAAGGT3′/5′GCTTTGAGTAAGAAGGTGTTG3′). (E)
cDNA sequence comparison reveals that plcβ3 splice-blocking MO variant
results from aberrant splicing to a cryptic splice site locate 51 bases 5′ of the
normal exon4 splice donor. The plcβ3 MO splice variant results in the deletion
of 17 amino acids within the PH domain of plcβ3.
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(Ednra) localized to neural crest cells (Clouthier et al., 1998;
Nair et al., in press; data not shown), we predict that Plcβ3
functions just downstream of Ednra and also be expressed
within neural crest cells. We compared expression of plcβ3 to
known markers of specific cell types by in situ analysis. At
24 hpf, plcβ3 mRNA is expressed in a second arch
mesenchymal domain similar to dlx2a, suggesting this domain
corresponds to postmigratory neural crest cells (Figs. 4A, C).
At 24 hpf, plcβ3 mRNA expression in the first and posterior
arch neural crest domains was very weak and variably
detectable (Fig. 4A, data not shown). At 28 hpf, plcβ3
mRNA expression in the second arch mesenchymal domain is
only weakly expressed, suggesting plcβ3 expression is
dynamically regulated. The timing of plcβ3 expression
makes sense if Plcβ3 function is required for Edn1-dependent
expression of Dlx genes and other transcription factors in
neural crest cells (Walker et al., 2006). At 24 hpf and 28 hpf,
we also observe plcβ3 expression in neuronal cell types,
including a subset of the trigeminal ganglia localized to a
dorsal position in the first arch adjacent to the first pouch,
similar to a domain of islet1 expression (Figs. 4A–C, see
arrowheads for comparison). In the trunk, plcβ3 is also
expressed in a subset of cells at an appropriate position to be
Rohon–Beard spinal sensory neurons, identified by their
position relative to the neural tube as compared to islet1
expression (Figs. 4E, F).
plcβ3 genetically interacts with edn1
To directly test whether plcβ3 and edn1 genetically interact,
we crossed plcβ3 and edn1 heterozygous fish and assayed
offspring for skeletal phenotypes. We observed only mild
skeletal phenotypes in offspring with loss of a single copy of
either plcβ3 or edn1, with a large percent of the single
heterozygotes being phenotypically wild type (Table 3). On
the other hand, none of the offspring with a combined loss of
one copy of plcβ3 and edn1 were phenotypically wild type.
Rather, in the combined heterozygotes we observed an
increase in the penetrance and severity of skeletal defects.
These skeletal defects included joint loss, ventral cartilage
reductions, ectopic cartilage nodules, and OP/BSR bone
phenotypes. These results support our model in which the
ligand Edn1 signaling through a G protein-coupled receptor to
activate Plcβ3.Fig. 3. A splice-blocking MO partially rescues plcβ3 homozygotes. (A–D)
Flatmounts of 5–6 dpf wild-type and plcβ3 homozygotes pharyngeal tissues
doubly stained with Alcian blue and Alizarin red for cartilage and bone,
respectively. (A) Uninjected wild type. (B) Injection of plcβ3 splice-blocking
MO into wild-type yields only mild phenotypes. Arrow indicates reduction of
symplectic cartilage. (C) plcβ3 homozygotes have a loss of jaw joints,
misshaped palatoquadrate cartilage, and a strong reduction of symplectic
(arrows) and ceratohyal cartilages (arrowheads). (D) Injection of plcβ3 splice-
blocking MO into plcβ3 heterozygotes partially rescues cartilage defects.
Arrows indicate reduction of symplectic cartilage. Asterisks indicate ectopic
cartilage nodule extending from palatoquadrate. Jaw joints and ceratohyal
cartilages are strongly rescued. Scale bar: 50 μm.
Fig. 4. plcβ3 is expressed in the pharyngeal arches and in neuronal cells. Lateral views of in situ hybridizations in wild-type embryos at 24 (A, C, E, F) and 28 hpf (B,
D). Anterior is to the left. At 24 and 28 hpf, plcβ3 is expressed in a first arch domain adjacent to the first pouch (A, B), similar to a subset of the islet1 trigeminal
ganglion domain (D). At 24 hpf, plcβ3 is also expressed in the second arch (A), similar to the dlx2a neural crest domain (C). At 28 hpf, plcβ3 is only weakly expressed
in the second arch neural crest domain (B). Lateral trunk views at the same axial level of plcβ3 (E) and islet1 (F) RNA in situ hybridizations with wild-type embryos at
24 hpf. plcβ3 is expressed in a subset of cells at appropriate positions to be Rohon–Beard spinal sensory neurons. a1 and a2 label pharyngeal arch 1 and 2. Dotted lines
label pharyngeal pouch 1. Arrowheads label cells at position of trigeminal ganglion domain. Scale bar: 50 μm.
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We analyzed expression of other genes in plcβ3 homo-
zygotes to determine if edn1-dependent gene expression was
also reduced in plcβ3 homozygotes. We have previously shown
that Edn1 signaling is required for the pharyngeal expression of
ventrally restricted Distalless (Dlx) transcription factors (Miller
et al., 2000; Walker et al., 2006). We assayed for Dlx gene
expression at 30 and 36 hpf to determine if plcβ3 is required for
both early and late Dlx gene expression. At 30 hpf, the
expressions of dlx5a, dlx6a, and dlx3b were strongly reduced
in both the first and second arches in homozygous plcβ3
mutants, while only the ventral expression of dlx2a was reducedTable 3
plcβ3 genetically interacts with edn1
Class Number
scored
Phenotypic index
1 (wt) 2 (mild) 3 (moderate) 4 (severe)
plcβ3 edn1
+/+ +/+ 31 100% 0% 0% 0%
+/− +/+ 37 78% 22% 0% 0%
+/+ +/− 29 45% 55% 0% 0%
+/− +/− 41 0% 49% 51% 0%
Offspring of a plcβ3th210/+xedn1tf216b/+cross were raised to 6 dpf.
The heads of larvae were fixed and stained for cartilage and bone and genomic
DNA for genotyping was prepared from the tails.
Scoring was done blindly, prior to determining genotype.
“Number scored” refers to larvae scored. Phenotypic classes were defined as in
Table 2.(Figs. 5E–H). At 36 hpf, the expression of dlx6a and dlx3b
remained strongly reduced, but the expression of dlx5a had
recovered dorsally but not ventrally in both the first and second
arches, and also around the stomodeum (Figs. 5N–P). The
dlx2a ventral expression domain defect was still evident at
36 hpf (Fig. 5M). In plcβ3 homozygotes we also observed a
general persistence of Dlx expression adjacent to pharyngeal
pouches. The ventral downregulation of Dlx expression is
similar in nature to what we observed in edn1 mutants and
suggests that a critical level of early Edn1 signaling that is
required for both early and late Dlx expression (Walker et al.,
2006) is not reached in homozygous plcβ3 mutants.
Intermediate and ventral pharyngeal arch domains are
miss-specified in plcβ3 mutants
The penetrance of anterior arch joint losses is 100% in both
plcβ3 homozygotes and edn1 mutants. In edn1 mutants,
expression of bapx1, a gene required for jaw joint formation,
fails to be expressed in the intermediate joint-forming domain of
the first arch (Miller et al., 2003). Thus, we predicted that bapx1
expression in the intermediate joint forming domain of the first
arch also would be strongly downregulated in plcβ3 homo-
zygotes. At 48 hpf, the expression of bapx1 within the first arch
intermediate domain is strongly reduced in homozygous plcβ3
mutants (Fig. 6G). On the other hand, severe ventral cartilage
reductions in arches 1–4 are not as penetrant in plcβ3
homozygotes compared to edn1 mutants (Table 1) (Miller et
Fig. 5. plcβ3 is required for edn1-dependent Dlx gene expression. Lateral views of in situ hybridizations in wild-type and plcβ3 homozygotes at 30 hpf (A–H) and
36 hpf (I–P). (A, E, I, M) dlx2a, (B, F, J, N) dlx5a, (C, G, K, O) dlx6a, and (D, H, L, P) dlx3b. At 30 hpf, expression of dlx2a is moderately affected in the most ventral
domain in plcβ3 homozygotes (E), and at 36 hpf dlx2a expression is clearly reduced in a ventral arch domain in both the first and second arches in plcβ3 homozygotes
(M). At 30 hpf, the expressions of dlx3b, dlx5a, and dlx6a are strongly reduced in both the first and second arches in plcβ3 homozygotes (F, G, H). At 36 hpf,
expressions of dlx6a and dlx3b are still strongly reduced in plcβ3 homozygotes (O, P). At 36 hpf, expression of dlx5a has recovered in a dorsal arch domain but is still
strongly reduced in intermediate and ventral arch domains (N). a1 and a2 label pharyngeal arch 1 and 2. Dotted lines label pharyngeal pouches 1 and 2 in panels A–P
and bottom of arch 1 and 2 in panels F, N, G, O, H, and P. Scale bar: 50 μm.
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further support placement of Plcβ3 within the Edn1 pathway,
we analyzed the expression of several edn1-dependent
transcription factors required for intermediate and ventral arch
patterning. We observe an early defect in hand2 expression in
plcβ3 homozygotes that recovers significantly by 55 hpf to
near wild-type levels in homozygous plcβ3 mutants (Fig. 6H).
But, in plcβ3 homozygotes there is a noticeable reduction in the
amount of ventral tissue that is hand2 positive at 55 hpf. edn1
mutants also show a reduction in ventral arch tissues (Walker et
al., 2006). We have previously analyzed the expression of
goosecoid (gsc) and barH-like homeobox 1 (barx) in edn1
mutants (Miller et al., 2000; Walker et al., 2006). In
homozygous plcβ3 mutants we observe ectopic expression of
these genes within the intermediate arch domains and a
reduction in their ventral arch expression (Figs. 6I, J). Finally,
we looked at the expression of the skeletal markers runx2b and
sox9a in homozygous plcβ3 mutants. Again, we find an
expansion of these markers into the intermediate arch domain,
and a reduction of their expression ventrally (Figs. 6K, L).Generally, the similarities of expression defects to edn1 mutants
and furinA mutants strongly support plcβ3 being an edn1
pathway gene. As the ventral expression of some of these
markers (hand2 and barx1) is not as strongly reduced in plcβ3
homozygotes compared to edn1 mutants, these data fit nicely
with the less penetrant severe ventral cartilage reductions we
observe in plcβ3 homozygotes.
Plcβ3 function is required in cranial neural crest cells for
intermediate and ventral arch fates
If Plcβ3 functions on the Edn1-pathway, we expect it to
function downstream from Edn1, hence in neural crest-derived
cells, the targets of Edn1 signaling. To test whether Plcβ3
function is required in these cells, or alternatively in surface
ectoderm or endoderm, to pattern the face, we unilaterally
transplanted wild-type cells from donor embryos into homo-
zygous plcβ3 mutant host embryos at shield stage (6 hpf) and
assayed for rescue of skeletal defects by comparing transplanted
side to non-transplanted sides at 5–6 dpf. We limited our
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donor tissue contributed to neural crest, ectoderm, or endoderm
in host embryo, as assayed at 30–36 hpf. We did not observe
rescue of skeletal defects with transplants containing either
surface ectoderm (0/12 transplants; Figs. 7B, E) or pharyngeal
endoderm (0/14 transplant; Figs. 7C, F). With transplants of
presumptive neural crest cells, we observed a strong rescue of
skeletal phenotypes on transplanted side of hosts compared to
non-transplanted side (12/12 transplants; Figs. 7A, D). The
rescued cartilage and bone was fli1:GFP positive, indicating
that wild-type fli1:GFP donor tissue contributed to rescued
cartilage and bone tissues in plcβ3 mutant host. In addition, we
observe rescue of ventral arch tissues in general, including
muscle patterning (Fig. 8). These results demonstrate that Plcβ3
function is required in neural crest cells and is not in other cell
types to pattern intermediate and ventral arch fates.
plcβ3−/− neural crest cells sort from wild-type neural crest cells
in mosaic embryos
We next performed reciprocal transplants to further test the
cell autonomous nature of Plcβ3 requirement in neural crest
cells for ventral cartilage formation. We transplanted wild-type
and plcβ3−/− neural crest cells into wild-type fli1:GFP host
embryos and assayed for skeletal phenotypes at 5–6 dpf. We
did not observe an induction of mutant phenotypes when
plcβ3−/− neural crest cells were transplanted into wild-type
hosts to support our conclusion from the opposite transplant
that Plcβ3 function is required within the skeletogenic crest
itself. However, we did observe a sorting behavior in which
plcβ−/− donor neural crest cells contributed significantly to
dorsal cartilages but not to intermediate and ventral cartilages
(Figs. 9B, D, F, H). Moreover, in a mosaic animal, wild-type
neural crest cells contributed largely to intermediate and
ventral cartilages but not to dorsal cartilages. When wild-type
donor neural crest cells were transplanted to a wild-type host,
the wild-type donor neural crest cells contributed to cartilages
located at any dorsoventral position within the pharyngeal
arch (Figs. 9A, C, E, G).
The sorting feature of the mosaics suggests that plcβ3−/−
neural crest cells are at a disadvantage in populating theFig. 6. Intermediate and ventral pharyngeal arch domains are misspecified in
plcβ3 mutants. Lateral views of in situ hybridizations in wild-type and plcβ3
homozygotes. (A, G) At 48 hpf, bapx1 expression in a first arch intermediate
domain is strongly reduced in plcβ3 homozygotes. (B, H) At 55 hpf, hand2
expression is at near wild-type levels in plcβ3 homozygotes. (C, I) At 48 hpf,
gsc is ectopically expressed in first and second arch intermediate domains and
strongly reduced in a second arch ventral domain in plcβ3 homozygotes. (D, J)
At 48 hpf, barx1 expression in the first and second arches is ectopically
expressed in intermediate domains and strongly reduced in ventral domains in
plcβ3 homozygotes. (E, K) At 55 hpf, runx2b is ectopically expressed in a
second arch intermediate domain and strongly reduced in a second arch ventral
domain in plcβ3 homozygotes. (F, L) At 48 hpf, sox9a expression is strongly
reduced in ventral domains of the first and second arches in plcβ3 homozygotes.
Arrowheads indicate first arch intermediate domain in wild-type embryos.
Arrows indicate second arch intermediate domains in wild-type embryos.
Asterisks indicate ectopic expression in intermediate arch domains in plcβ3
homozygotes. a1 and a2 label pharyngeal arch 1 and 2. Scale bar: 50 μm.
Fig. 7. plcβ3 is required in cranial neural crest cells for pharyngeal arch patterning. (A–C) Projections of confocal z-stacks, including fluorescent and bright-field
channels, of lateral and orthogonal views of live 36 hpf mosaic host embryos. (A) Cells from the animal pole of Alexa568-labeled sphere staged (6 hpf) wild-type fli:
GFP donors were transplanted unilaterally into (A) the neural crest domain, (B) the surface ectoderm domain, and (C) the endoderm domain of plcβ3 homozygous
hosts. Embryos were screened at 30–36 hpf to determine contribution of donor cells to pharyngeal arches and again at 6 dpf to assess contribution of donor cells to
cartilages. Dots indicate bottom of the first pharyngeal pouch. Green florescence indicates presence of fli-positive donor neural crest in transplants in panel A and
absence of green florescence indicates absence of neural crest in transplants in panels B and C. (D–F) Embryos imaged in panels A–C were subsequently fixed and
doubly stained for both cartilage (Alcian blue) and bone (Alizarin red). Non-transplant sides of hosts were used as negative controls for rescue. As brain tissues
frequently accompany large neural crest transplants, we also analyzed transplants containing only brain tissue and determined they did not rescue (n=5, data not
shown). Scale bars: 50 μm.
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wild-type neural crest cells (see Discussion). With very large
transplants we do observe a small fraction of plcβ3−/− neural
crest cells contributing to intermediate and ventral cartilages
(data not shown).
Discussion
We show that schmerle encodes a zebrafish ortholog of Plcβ3
required for intermediate and ventral pharyngeal arch fates. plcβ3
homozygotes have jaw phenotypes similar to Edn1 mutants, while
plcβ3 heterozygotes have similar but much milder facial defects.
Edn1 signals through a G protein-coupled receptor to activate Plcβ
type enzymes. Our study clarifies which Plcβ family member(s)
are critical for facial patterning as none of the single mouse
mutants in Plcβ family member(s) yielded skeletal phenotypes.
Our analysis of plcβ3 mutant zebrafish demonstrates that plcβ3 is
a critical effector of Edn1 signaling in cranial neural crest cells.
Furthermore, the dominant-negative phenotypes we observe
suggest other Plcβ family members can function within the
edn1 pathway as well. Perhaps a redundancy for Plcβ function
among family members extends to mouse facial patterning,explaining why the loss of a single Plcβ family member in mice
does not result in facial skeletal defects.
Independent catalytic domain mutations in plcβ3 are partially
dominant negative
Two independent plcβ3 alleles, plcβ3th210 and plcβ3tg203e,
yield similar skeletal phenotypes, and both have lesions in
conserved catalytic residues, within the X and Y domains,
respectively. Heterozygous plcβ3 mutants have mild facial
skeletal defects suggestive of a partial loss of Edn1 signaling,
while homozygous plcβ3 mutants have severe facial skeletal
defects resembling a strong loss of Edn1 function. plcβ3 MO
injected embryos have mild phenotypes similar to heterozygous
plcβ3 mutants. We show that injection of a splice-blocking MO
designed to the N-terminal PH domain in Plcβ3 can partially
rescue the facial skeletal defects in homozygous plcβ3 mutants.
How can we understand these results?
To explain, we hypothesize that the partially dominant plcβ3
mutations act in a-negative manner due to lesions in conserved
residues within the catalytic domains, resulting in catalytically
inactive enzymes. Nagano et al. provide evidence to support the
Fig. 8. plcβ3 is required in cranial neural crest cells for ventral pharyngeal
muscle patterning. Flat mount in Fig. 7D was subsequently imaged with DIC to
show muscle patterning. On transplant side wild-type neural crest cells partially
rescue patterning of several ventral arch muscles. On non-transplant side,
muscle fibers are largely disorganized. Muscles are abbreviated as follows:
intermandibularis posterior (imp), interhyal (ih), hypohyal (hh) ((Schilling and
Kimmel, 1997). Asterisks (*) indicate disorganized muscle fibers on non-
transplant side of plcβ3 homozygous host. Scale bar: 50 μm.
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through analysis of a Plcδ4 splice variant, termed ALT III,
which lacks catalytic activity due to altered splicing of the
catalytic X domain (Nagano et al., 1999). The authors
demonstrate that the inactive splice variant acts as a negative
regulator not only of Plcδ4, but of other PLC enzymes as well,
and that its PH domain is necessary and sufficient for this
inhibition. When ALT III was co-expressed with full-length
PLCδ4, ALT III inhibited the PLC activity of PLCδ4.
Furthermore, the PH domain alone but not a PH domain
deletion construct of ALT III could inhibit the PLC activity of
PLCδ4. These results show that the PH domain is necessary and
sufficient for the inhibitory effect on PLCδ4 activity. ALT III
was also found to inhibit the activity of other PLC enzymes,
with inhibition most effective against PLCδ type enzymes. As
ALT III is expressed at high levels within certain tissues and cell
types, ALT III may function as a negative regulator of PLCδ
type enzymes within specific developmental and/or cellular
contexts. In addition, catalytically inactive forms of PLC-like
proteins have also been identified (Plcl1 and Plcl2), suggesting
an emerging family of proteins that may function as modulators
of important signaling pathways (Otsuki et al., 1999; Takeuchi
et al., 2000). Mouse mutants deficient in Plcl1 and Plcl2 have
been constructed and initial analysis of these mutants supportthe hypothesis that catalytically inactive PLC-like genes have
important functions as modulators of multiple signaling path-
ways (Kanematsu et al., 2002; Takenaka et al., 2003; Terunuma
et al., 2004).
Nagano's findings can help explain why we observe
dominant phenotypes in plcβ3 catalytic domain mutants. If
the dominance of the plcβ3 alleles is mediated through either
membrane localization or substrate binding, a deletion in the PH
domain could reverse the dominance, as PH domains have
clearly been shown to mediate membrane localization (Lemmon
and Ferguson, 2000; Razzini et al., 2000; Varnai et al., 2002).
Thus, a failure to locate to the membrane could relieve a
negative regulatory effect on PLC signaling. In this respect,
Plcβ3 membrane localization may be necessary to recruit
other proteins to form a signaling complex. If so, a catalytically
inactive Plcβ3 with an intact PH domain could possibly form an
inactive signaling complex, and thus act in a negative regulatory
manner on Plcβ-mediated signaling. We demonstrate that a
splice-blocking MO which deletes part of the PH domain of
Plcβ3 is effective at rescuing the dominant-negative phenotypes
of the plcβ3 catalytic domain mutations, strongly supporting
our hypothesis that the plcβ3 catalytic domain mutations affect
the function of other Plcβ family members.
Previous studies did not identify schmerle (plcβ3) alleles as
partially dominant mutations (Kimmel et al., 1998; Kimmel et
al., 2003a; Piotrowski et al., 1996). The schmerle mutant has
always been recognized as highly variable in phenotype, but the
dominance of the mutations was not appreciated until cloning
and genotyping revealed that the subtle phenotypes segregated
to heterozygotes and the strong phenotypes to homozygotes. In
addition, our identification and study of other mutants within
the Edn1 pathway has enabled us to recognize the subtle
cartilage nubbins and bone fusions in plcβ3 heterozygotes as
recurring themes in Edn1 pathway mutants (data not shown)
(Miller et al., 2000; Walker et al., 2006).
Plcβ3 functions within the Edn1 signaling pathway
The skeletal phenotype of homozygous plcβ3 mutants is
similar to those of furinA and edn1mutants. We have previously
shown that furinA genetically interacts with edn1, and in this
paper we show that plcβ3 also genetically interacts with edn1.
Furthermore, all three mutants have defects in the same facial
skeletal elements but to varying degrees of penetrance and
expressivity. Homozygous plcβ3 mutants have a high expres-
sivity of fusions in the joint regions of the first and second arch,
and a somewhat milder reduction in the length of the lower jaw
(first arch) compared to reduction in the length of the ventral
cartilage of the second arch. This phenotype is similar to edn1
mutants but the defects in ventral cartilage reduction are more
penetrant in edn1 mutants than in plcβ3 homozygotes (Miller et
al., 2000). On the other hand, furinA mutants have a lower
expressivity of joint fusions and ventral cartilage reductions in
both the first and second arch compared to plcβ3 heterozygotes.
Thus, furinA mutants are phenotypically milder than homo-
zygous plcβ3 mutants in terms of facial skeletal defects.
Injections of endothelin1 MO at different doses can phenocopy
Fig. 9. plcβ3−/− neural crest cells sort from wild-type neural crest cells in mosaic embryos. (A–F) Confocal fluorescent stacks of live 6 dpf mosaic host embryos. (A, C,
E) Wild-type Alexa568-labeled neural crest cells were transplanted into wild-type fli:GFP hosts at sphere stage (6 hpf). Wild-type donor cells contributed to (A)
hyomandibular (hm), (C) symplectic (sy), (E) interhyal (ih), and ceratohyal (ch) cartilages. (B, D, F) plcβ3 homozygous Alexa568-labeled neural crest cells were
transplanted into wild-type fli:GFP hosts at sphere stage (6 hpf). plcβ3 mutant donor cells contributed significantly to (B) hyomandibular, but not to (D) symplectic,
(F) interhyal, or ceratohyal cartilages. (G, H) Schematic of cell sorting observed in mosaic transplants. (G) Wild-type to wild-type transplants did not sort, whereas (H)
mutant to wild-type transplants sorted. Red indicates donor and green indicates hosts. Scale bar: 50 μm.
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et al., 2003a; Miller and Kimmel, 2001). We hypothesize that
homozygous plcβ3 mutants have a stronger defect in Edn1
signaling than furinA mutants. Analysis of edn1-dependent Dlx
gene expression in furinA and homozygous plcβ3 mutants
supports this hypothesis. At 30 hpf, the arch expression of
dlx5a, dlx6a, and dlx3b are strongly reduced in homozygous
plcβ3 mutants, as we show here, but only moderately reduced
in furinA mutants (Walker et al., 2006). At 36 hpf, the
expression of these Dlx genes have significantly recovered in
furinA mutants but is still strongly reduced in homozygous
plcβ3 mutants. These results demonstrate that a critical level of
early Edn1 signaling, that is required for late Dlx gene
expression, is reached in furinA mutants but not in homozygous
plcβ3 mutants or edn1 mutants.
However, analysis of other edn1-dependent transcription
factors, particularly that of hand2, distinguishes betweenhomozygous plcβ3 and edn1 mutants in terms of severity of
expression defects. We have previously shown by mutational
analyses that hand2 is an edn1-dependent transcription factor
required for the formation of the ventral cartilages of the
anterior arches (Miller et al., 2000, 2003). hand2 expression at
55 hpf (i.e., at a very late stage of patterning) is at near wild-type
levels in homozygous plcβ3 mutants (Fig. 6H) but is strongly
reduced in edn1 mutants (Walker et al., 2006). This reduction in
edn1 mutants, but not in homozygous plcβ3 mutants, suggests
that based on hand2 expression, edn1 mutants have stronger
defects in Edn1 signaling than homozygous plcβ3 mutants. It is
interesting that homozygous plcβ3 mutants have near wild-type
levels of late hand2 expression because homozygous plcβ3
mutants typically have severe reductions of the ventral cartilage
of the second arch. Before our study it was possible to
understand the ventral cartilage loss in edn1 mutants as being
entirely due to downregulation of hand2 (Miller et al., 2003).
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and ventral cartilage phenotype suggests that other factors in
addition to hand2 are required for ventral cartilage formation.
Part of the reduction in ventral cartilage formation in plcβ3
homozygotes may be due to a general reduction in tissues
which express hand2, rather than a reduction in the hand2
signal per se.
In addition, the most ventral cartilage in the second arch
persists in plcβ3 homozygotes as cartilage nubbins, suggesting
a graded requirement for Edn1 function along the length of the
ventral cartilage. This concept of graded requirement for Edn1
function ties into our previous model in which intermediate arch
domains are more sensitive to reductions in Edn1 signal than
ventral arch domains (Miller et al., 2003; Walker et al., 2006).
The study of Edn1 pathway mutants with varying reductions in
Edn1 signaling has enabled us to understand more fully the
requirements for Edn1 function in specific skeletal elements.
Plcβ3 function is required autonomously in cranial neural crest
cells for pharyngeal arch patterning
We show that Plcβ3 functions autonomously in cartilage-
making tissue. When wild-type neural crest cells are trans-
planted into a homozygous plcβ3 mutant host we observe a
strong rescue of the facial skeleton on the transplanted side of
the plcβ3 mutant host at 6 dpf. If Plcβ3 functions within the
Edn1 signaling pathway as we argue above, it is downstream of
Edn1, which is expressed by signaling cells, and also down-
stream to the membrane spanning G-coupled receptor, Ednra,
expressed in neural crest cells. The timing of expression of
plcβ3 in neural crest cells fits nicely with this hypothesis.
Our rescue experiments also reveal that Plcβ3 functions
non-autonomously in neural crest cells to pattern surrounding
tissues, possibly including muscle patterning. This function of
Plcβ3 in patterning muscles supports our earlier hypothesis that
Edn1 signaling specifies ventral neural crest cell fates, including
ventral cartilages, bones, and connective tissues, and that these
ventrally specified neural crest cells then signal back to
mesoderm to allow correct patterning of ventral muscles (Miller
et al., 2000). Similarly, Kontges and Lumsden (1996)
hypothesize specifically that neural crest-derived connective
tissue which inserts into muscle patterns mesoderm-derived
muscle fibers. Availability of a cell-autonomous mutation acting
in neural crest will let us examine this proposition critically by
constructing mosaics in which only muscle connective tissue is
mutant.
Mosaic sorting of plcβ3 mutant neural crest cells
When Clouthier et al. (2003) generated chimeric mouse
embryos using Ednra mutant embryonic stem cells, they
observed that Ednra mutant cells were excluded from the
caudal–ventral aspects of the pharyngeal arches. Furthermore,
in a few embryos in which Ednra mutant cells did populate this
region of the arch, they did not contribute to structures that are
derived from this region (Clouthier et al., 2003). Our mosaic
experiments with plcβ3 mutants yields similar results in termsof exclusion of plcβ3mutants cells from ventral arch, but unlike
Clouthier et al. we observe that plcβ3 mutant cells can
contribute to ventral cartilages. Indeed, in plcβ3 homozygotes
we also observe a small percent of mutants with ventral
cartilages. These differences could be due to plcβ3 mutations
not fully inactivating the Edn1 pathway.
We hypothesize that Edn1 signaling promotes expansion of
cells in the ventral arch to support Edn1-dependent arch
elongation (Walker et al., 2006). In situ analysis with PCNA and
BrdU labeling has shown the ventral arch to be a highly
proliferative zone (Plaster et al., 2006) so the expansion may be
brought about by cell division, as we are examining in
experiments in progress. Plcβ3 function may be required cell-
autonomously for neural crest cells to proliferate and contribute
significantly to ventral cartilages, in response to Edn1 signaling.
Mosaic analysis of plcβ3 mutant neural crest cells in an edn1
mutant host will enable us to further determine if the mosaic
sorting we observe when plcβ3 mutant neural crest cells
confront wild-type crest cells is Edn1-dependent, as we
propose.
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